Literature DB >> 14120081

DICHLORPHENAMIDE, A POTENT CARBONIC ANHYDRASE INHIBITOR. EFFECT ON ALVEOLAR VENTILATION, VENTILATION-PERFUSION RELATIONSHIPS AND DIFFUSION IN PATIENTS WITH CHRONIC LUNG DISEASE.

R DORRIS, J V OLIVIA, T RODMAN.   

Abstract

Entities:  

Keywords:  ACIDOSIS; ACIDOSIS, RESPIRATORY; BLOOD GAS ANALYSIS; CARBONIC ANHYDRASE; CARBONIC ANHYDRASE INHIBITORS; DICHLORPHENAMIDE; ENZYME INHIBITORS; PULMONARY EMPHYSEMA; RESPIRATORY FUNCTION TESTS

Mesh：

Substances：

Year:  1964        PMID： 14120081     DOI： 10.1016/0002-9343(64)90150-0

Source DB:  PubMed          Journal:  Am J Med        ISSN： 0002-9343            Impact factor:   4.965


× No keyword cloud information.
  5 in total

1.  ORAL RESPIRATORY STIMULANTS IN CHRONIC RESPIRATORY FAILURE: DOUBLE-BLIND CONTROLLED TRIAL OF AMIPHENAZOLE AND DICHLORPHENAMIDE.

Authors:  W M NELSON; W F WALLACE
Journal:  Br Med J       Date:  1965-03-20

2.  Acetazolamide for prevention of contrast-induced nephropathy: a new use for an old drug.

Authors:  Farahnak Assadi
Journal:  Pediatr Cardiol       Date:  2006 Mar-Apr       Impact factor: 1.655

3.  Chronic respiratory failure in COPD: is there a place for a respiratory stimulant?

Authors:  P A Bardsley
Journal:  Thorax       Date:  1993-08       Impact factor: 9.139

4.  Rate of disappearance of labeled carbon dioxide from the lungs of humans during breath holding: a method for studying the dynamics of pulmonary CO2 exchange.

Authors:  R W Hyde; R J Puy; W F Raub; R E Forster
Journal:  J Clin Invest       Date:  1968-07       Impact factor: 14.808

5.  Adjunctive acetazolamide therapy for the treatment of Bartter syndrome.

Authors:  Mojgan Mazaheri; Farahnak Assadi; Simin Sadeghi-Bojd
Journal:  Int Urol Nephrol       Date:  2019-12-09       Impact factor: 2.370
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.